Oppenheimer Asset Management Inc. Charles River Laboratories International, Inc. Transaction History

Oppenheimer Asset Management Inc.

  • $8.4 Billion
  • Q2 2025

A detailed history of Oppenheimer Asset Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 23,347 shares of CRL stock, worth $4.56 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
23,347
Previous 37,576 37.87%
Holding current value
$4.56 Million
Previous $5.66 Million 37.37%
% of portfolio
0.04%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$99.75 - $151.89 $1.42 Million - $2.16 Million
-14,229 Reduced 37.87%
23,347 $3.54 Million
Q1 2025

Apr 22, 2025
BUY
$150.52 - $190.14 $703,078 - $888,143
4,671 Added 14.2%
37,576 $5.66 Million
Q4 2024

Feb 04, 2025
SELL
$178.58 - $220.69 $2.44 Million - $3.01 Million
-13,651 Reduced 29.32%
32,905 $6.07 Million
Q3 2024

Nov 05, 2024
SELL
$187.96 - $245.29 $185,892 - $242,591
-989 Reduced 2.08%
46,556 $9.17 Million
Q2 2024

Aug 08, 2024
BUY
$206.39 - $268.73 $873,236 - $1.14 Million
4,231 Added 9.77%
47,545 $9.82 Million
Q1 2024

May 06, 2024
SELL
$203.52 - $273.43 $210,439 - $282,726
-1,034 Reduced 2.33%
43,314 $11.7 Million
Q4 2023

Feb 13, 2024
SELL
$164.52 - $238.84 $607,078 - $881,319
-3,690 Reduced 7.68%
44,348 $10.5 Million
Q3 2023

Nov 07, 2023
SELL
$194.44 - $217.61 $146,218 - $163,642
-752 Reduced 1.54%
48,038 $9.41 Million
Q2 2023

Aug 02, 2023
BUY
$183.71 - $210.25 $348,314 - $398,634
1,896 Added 4.04%
48,790 $10.3 Million
Q1 2023

May 10, 2023
BUY
$191.89 - $259.92 $967,317 - $1.31 Million
5,041 Added 12.04%
46,894 $9.46 Million
Q4 2022

Feb 06, 2023
SELL
$197.11 - $250.07 $45,138 - $57,266
-229 Reduced 0.54%
41,853 $9.12 Million
Q3 2022

Nov 14, 2022
BUY
$182.44 - $250.54 $1.18 Million - $1.62 Million
6,447 Added 18.09%
42,082 $8.28 Million
Q2 2022

Aug 08, 2022
SELL
$204.13 - $302.4 $78,181 - $115,819
-383 Reduced 1.06%
35,635 $7.63 Million
Q1 2022

May 12, 2022
BUY
$255.51 - $362.11 $2.14 Million - $3.03 Million
8,367 Added 30.26%
36,018 $10.2 Million
Q4 2021

Feb 02, 2022
BUY
$351.38 - $448.68 $487,012 - $621,870
1,386 Added 5.28%
27,651 $10.4 Million
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $781,798 - $961,513
-2,098 Reduced 7.4%
26,265 $10.8 Million
Q2 2021

Aug 03, 2021
BUY
$294.17 - $371.65 $166,206 - $209,982
565 Added 2.03%
28,363 $10.5 Million
Q1 2021

May 17, 2021
BUY
$249.67 - $299.48 $2.79 Million - $3.35 Million
11,190 Added 67.38%
27,798 $8.06 Million
Q4 2020

Feb 11, 2021
SELL
$222.0 - $252.62 $105,450 - $119,994
-475 Reduced 2.78%
16,608 $4.15 Million
Q3 2020

Nov 13, 2020
SELL
$175.56 - $226.45 $650,274 - $838,770
-3,704 Reduced 17.82%
17,083 $3.87 Million
Q2 2020

Aug 11, 2020
BUY
$118.84 - $189.72 $243,265 - $388,356
2,047 Added 10.92%
20,787 $3.62 Million
Q1 2020

May 08, 2020
SELL
$98.9 - $178.34 $6,032 - $10,878
-61 Reduced 0.32%
18,740 $2.37 Million
Q4 2019

Feb 07, 2020
BUY
$126.05 - $152.76 $34,537 - $41,856
274 Added 1.48%
18,801 $2.87 Million
Q3 2019

Oct 31, 2019
SELL
$125.07 - $143.67 $1,000 - $1,149
-8 Reduced 0.04%
18,527 $2.45 Million
Q2 2019

Aug 09, 2019
BUY
$123.4 - $148.55 $150,301 - $180,933
1,218 Added 7.03%
18,535 $2.63 Million
Q1 2019

Apr 24, 2019
SELL
$104.82 - $146.73 $41,508 - $58,105
-396 Reduced 2.24%
17,317 $2.52 Million
Q4 2018

Jan 30, 2019
BUY
$105.09 - $137.23 $945 - $1,235
9 Added 0.05%
17,713 $2.01 Million
Q3 2018

Oct 26, 2018
SELL
$112.11 - $134.54 $21,861 - $26,235
-195 Reduced 1.09%
17,704 $2.38 Million
Q2 2018

Aug 10, 2018
SELL
$102.37 - $117.25 $307,314 - $351,984
-3,002 Reduced 14.36%
17,899 $2.01 Million
Q1 2018

May 09, 2018
BUY
$98.19 - $115.2 $170,948 - $200,563
1,741 Added 9.09%
20,901 $2.23 Million
Q3 2017

Nov 14, 2017
BUY
$96.72 - $109.26 $1.85 Million - $2.09 Million
19,160
19,160 $2.07 Million

Others Institutions Holding CRL

# of Institutions
632
Shares Held
52.7M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.93B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email